Publication:
Serum quinine concentrations following the initial dose in children with falciparum malaria

dc.contributor.authorA. Sabchareonen_US
dc.contributor.authorT. Chongsuphajaisiddhien_US
dc.contributor.authorP. Attanathen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-12T07:27:11Z
dc.date.available2018-10-12T07:27:11Z
dc.date.issued1982-12-01en_US
dc.description.abstractSerum quinine concentrations were determined in 51 children with uncomplicated falciparum malaria and 22 controls. Quinine 10 mg salt/kg was given one-hour, two-hour, four-hour intravenously in group A (14 patients, 5 controls), group B (12 patients, 6 controls), Group C (10 patients, 6 controls) and given orally in group D (15 patients, 5 controls). In malaria patients, the highest serum quinine levels were observed at the end of intravenous infusion and by the 4th hour after oral medication. Mean of the peaks of the drug concentrations of the 4 schedules were not significantly different, ranging from 22 to 28 n mol/ml. Serum concentrations in the patients were significantly higher than those of the controls. The total clearance of quinine in the patients were approx. 1 ml/min/kg, which was significantly less than those of the controls. The total apparent volume of distribution of the drug was similarily reduced. In patients it was about 0.8 litre/kg. The elimination half times of quinine ranged from 9 to 11 hours, whereas the value in the controls ranged from 3 to 7 hours. Side effects of quinine were not observed.en_US
dc.identifier.citationSoutheast Asian Journal of Tropical Medicine and Public Health. Vol.13, No.4 (1982), 556-562en_US
dc.identifier.issn00383619en_US
dc.identifier.other2-s2.0-0020283003en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/30357
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020283003&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSerum quinine concentrations following the initial dose in children with falciparum malariaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0020283003&origin=inwarden_US

Files

Collections